RU2012122700A - Структура сокристалла фактора d и антитела к фактору d - Google Patents
Структура сокристалла фактора d и антитела к фактору d Download PDFInfo
- Publication number
- RU2012122700A RU2012122700A RU2012122700/10A RU2012122700A RU2012122700A RU 2012122700 A RU2012122700 A RU 2012122700A RU 2012122700/10 A RU2012122700/10 A RU 2012122700/10A RU 2012122700 A RU2012122700 A RU 2012122700A RU 2012122700 A RU2012122700 A RU 2012122700A
- Authority
- RU
- Russia
- Prior art keywords
- factor
- polypeptide
- antibody
- crystal
- seq
- Prior art date
Links
- 239000013078 crystal Substances 0.000 title claims abstract 30
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract 22
- 229920001184 polypeptide Polymers 0.000 claims abstract 21
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract 21
- 239000012634 fragment Substances 0.000 claims abstract 15
- 239000000427 antigen Substances 0.000 claims abstract 10
- 102000036639 antigens Human genes 0.000 claims abstract 10
- 108091007433 antigens Proteins 0.000 claims abstract 10
- 241000282567 Macaca fascicularis Species 0.000 claims abstract 6
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 claims abstract 3
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 claims abstract 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 2
- 238000006467 substitution reaction Methods 0.000 claims abstract 2
- 125000000539 amino acid group Chemical group 0.000 claims 7
- 238000000034 method Methods 0.000 claims 6
- 150000001875 compounds Chemical class 0.000 claims 5
- 239000001648 tannin Substances 0.000 claims 5
- 238000013500 data storage Methods 0.000 claims 4
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- 238000002441 X-ray diffraction Methods 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 claims 2
- 230000003197 catalytic effect Effects 0.000 claims 2
- 239000011232 storage material Substances 0.000 claims 2
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Animal Behavior & Ethology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28046009P | 2009-11-04 | 2009-11-04 | |
| US61/280,460 | 2009-11-04 | ||
| US28171609P | 2009-11-20 | 2009-11-20 | |
| US61/281,716 | 2009-11-20 | ||
| PCT/US2010/055509 WO2011057014A1 (en) | 2009-11-04 | 2010-11-04 | Co-crystal structure of factor d and anti-factor d antibody |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2012122700A true RU2012122700A (ru) | 2013-12-10 |
Family
ID=43303899
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2012122700/10A RU2012122700A (ru) | 2009-11-04 | 2010-11-04 | Структура сокристалла фактора d и антитела к фактору d |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20110165648A1 (enExample) |
| EP (1) | EP2496695A1 (enExample) |
| JP (1) | JP2013509866A (enExample) |
| KR (1) | KR20120120153A (enExample) |
| CN (1) | CN102666850A (enExample) |
| AR (1) | AR078886A1 (enExample) |
| BR (1) | BR112012011607A2 (enExample) |
| CA (1) | CA2782481A1 (enExample) |
| IN (1) | IN2012DN03338A (enExample) |
| MX (1) | MX2012005430A (enExample) |
| RU (1) | RU2012122700A (enExample) |
| TW (1) | TW201121993A (enExample) |
| WO (1) | WO2011057014A1 (enExample) |
| ZA (1) | ZA201202602B (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CR20170001A (es) | 2008-04-28 | 2017-08-10 | Genentech Inc | Anticuerpos anti factor d humanizados |
| US8765432B2 (en) | 2009-12-18 | 2014-07-01 | Oligasis, Llc | Targeted drug phosphorylcholine polymer conjugates |
| US10093978B2 (en) | 2013-08-12 | 2018-10-09 | Genentech, Inc. | Compositions for detecting complement factor H (CFH) and complement factor I (CFI) polymorphisms |
| EP3041513B1 (en) | 2013-09-08 | 2020-08-05 | Kodiak Sciences Inc. | Factor viii zwitterionic polymer conjugates |
| AU2015253042A1 (en) | 2014-05-01 | 2016-10-20 | Genentech, Inc. | Anti-factor D antibody variants and uses thereof |
| US9840553B2 (en) | 2014-06-28 | 2017-12-12 | Kodiak Sciences Inc. | Dual PDGF/VEGF antagonists |
| CN107208076A (zh) | 2014-10-17 | 2017-09-26 | 科达制药 | 丁酰胆碱酯酶两性离子聚合物缀合物 |
| JP2018536650A (ja) | 2015-10-30 | 2018-12-13 | ジェネンテック， インコーポレイテッド | 抗ｄ因子抗体変異体コンジュゲート及びその使用 |
| US10407510B2 (en) | 2015-10-30 | 2019-09-10 | Genentech, Inc. | Anti-factor D antibodies and conjugates |
| CA3003647A1 (en) * | 2015-10-30 | 2017-05-04 | Genentech, Inc. | Anti-factor d antibody formulations |
| KR102799807B1 (ko) | 2015-12-30 | 2025-04-24 | 코디악 사이언시스 인코포레이티드 | 항체 및 이의 접합체 |
| CA3011819A1 (en) * | 2016-01-20 | 2017-07-27 | Vitrisa Therapeutics, Inc. | Compositions and methods for inhibiting factor d |
| WO2018136827A1 (en) | 2017-01-20 | 2018-07-26 | Vitrisa Therapeutics, Inc. | Stem-loop compositions and methods for inhibiting factor d |
| CA3059938A1 (en) * | 2017-04-14 | 2018-10-18 | Kodiak Sciences Inc. | Complement factor d antagonist antibodies and conjugates thereof |
| CN112203679A (zh) | 2018-03-02 | 2021-01-08 | 科达制药股份有限公司 | Il-6抗体及其融合构建体和缀合物 |
| US11912784B2 (en) | 2019-10-10 | 2024-02-27 | Kodiak Sciences Inc. | Methods of treating an eye disorder |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4736866B1 (en) | 1984-06-22 | 1988-04-12 | Transgenic non-human mammals | |
| IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
| JP3040121B2 (ja) | 1988-01-12 | 2000-05-08 | ジェネンテク，インコーポレイテッド | 増殖因子レセプターの機能を阻害することにより腫瘍細胞を処置する方法 |
| DE68913658T3 (de) | 1988-11-11 | 2005-07-21 | Stratagene, La Jolla | Klonierung von Immunglobulin Sequenzen aus den variablen Domänen |
| US6291161B1 (en) | 1989-05-16 | 2001-09-18 | Scripps Research Institute | Method for tapping the immunological repertiore |
| CA2016841C (en) | 1989-05-16 | 1999-09-21 | William D. Huse | A method for producing polymers having a preselected activity |
| US6291160B1 (en) | 1989-05-16 | 2001-09-18 | Scripps Research Institute | Method for producing polymers having a preselected activity |
| CA2016842A1 (en) | 1989-05-16 | 1990-11-16 | Richard A. Lerner | Method for tapping the immunological repertoire |
| US6291159B1 (en) | 1989-05-16 | 2001-09-18 | Scripps Research Institute | Method for producing polymers having a preselected activity |
| US6291158B1 (en) | 1989-05-16 | 2001-09-18 | Scripps Research Institute | Method for tapping the immunological repertoire |
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| AU638762B2 (en) | 1989-10-05 | 1993-07-08 | Optein Inc | Cell-free synthesis and isolation of novel genes and polypeptides |
| US5244800A (en) * | 1990-04-27 | 1993-09-14 | The Uab Research Foundation | Crystals of human complement factor d that are triclinic |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| ATE297465T1 (de) | 1991-11-25 | 2005-06-15 | Enzon Inc | Verfahren zur herstellung von multivalenten antigenbindenden proteinen |
| ATE408012T1 (de) | 1991-12-02 | 2008-09-15 | Medical Res Council | Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken |
| US6956107B2 (en) | 1998-02-20 | 2005-10-18 | Tanox, Inc. | Inhibitors of complement activation |
| JP4753578B2 (ja) | 2002-06-03 | 2011-08-24 | ジェネンテック， インコーポレイテッド | 合成抗体ファージライブラリー |
| KR20140101873A (ko) * | 2006-11-02 | 2014-08-20 | 제넨테크, 인크. | 인간화 항-ｄ 인자 항체 |
| AR066660A1 (es) * | 2007-05-23 | 2009-09-02 | Genentech Inc | Prevencion y tratamiento de condiciones del ojo asociadas con su complemento |
| CR20170001A (es) * | 2008-04-28 | 2017-08-10 | Genentech Inc | Anticuerpos anti factor d humanizados |
-
2010
- 2010-11-03 US US12/927,009 patent/US20110165648A1/en not_active Abandoned
- 2010-11-04 CN CN2010800568895A patent/CN102666850A/zh active Pending
- 2010-11-04 BR BR112012011607-0A patent/BR112012011607A2/pt not_active Application Discontinuation
- 2010-11-04 JP JP2012537229A patent/JP2013509866A/ja active Pending
- 2010-11-04 TW TW099137982A patent/TW201121993A/zh unknown
- 2010-11-04 KR KR1020127014237A patent/KR20120120153A/ko not_active Withdrawn
- 2010-11-04 AR ARP100104082A patent/AR078886A1/es unknown
- 2010-11-04 WO PCT/US2010/055509 patent/WO2011057014A1/en not_active Ceased
- 2010-11-04 RU RU2012122700/10A patent/RU2012122700A/ru not_active Application Discontinuation
- 2010-11-04 EP EP10774413A patent/EP2496695A1/en not_active Withdrawn
- 2010-11-04 IN IN3338DEN2012 patent/IN2012DN03338A/en unknown
- 2010-11-04 MX MX2012005430A patent/MX2012005430A/es not_active Application Discontinuation
- 2010-11-04 CA CA2782481A patent/CA2782481A1/en not_active Abandoned
-
2012
- 2012-04-11 ZA ZA2012/02602A patent/ZA201202602B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2782481A1 (en) | 2011-05-12 |
| TW201121993A (en) | 2011-07-01 |
| BR112012011607A2 (pt) | 2020-06-02 |
| AR078886A1 (es) | 2011-12-07 |
| EP2496695A1 (en) | 2012-09-12 |
| ZA201202602B (en) | 2013-06-26 |
| IN2012DN03338A (enExample) | 2015-10-23 |
| MX2012005430A (es) | 2012-06-19 |
| US20110165648A1 (en) | 2011-07-07 |
| KR20120120153A (ko) | 2012-11-01 |
| WO2011057014A1 (en) | 2011-05-12 |
| CN102666850A (zh) | 2012-09-12 |
| JP2013509866A (ja) | 2013-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2012122700A (ru) | Структура сокристалла фактора d и антитела к фактору d | |
| RU2491293C2 (ru) | Иммунологические анализы активности ботулинического токсина серотипа а | |
| Nelson et al. | Reference range for the antimüllerian hormone Generation II assay: a population study of 10,984 women, with comparison to the established Diagnostics Systems Laboratory nomogram | |
| Keller et al. | Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD) | |
| Potocki et al. | Mid-regional pro-adrenomedullin in acute heart failure: a better biomarker or just another biomarker? | |
| RU2012112046A (ru) | Антитело против ilt17 | |
| RU2012110578A (ru) | Способы и композиции для лечения фиброзных заболеваний легких | |
| JP7603023B2 (ja) | 心不全を評価するためのアッセイ | |
| RU2013102113A (ru) | Биомаркеры для прогнозирования возникновения рака | |
| US20190041397A1 (en) | Method to screen high affinity antibody | |
| CN108431606B (zh) | 纤维化的联合生物标志物测量 | |
| RU2711719C2 (ru) | Способ улучшения стабильности антител | |
| WO2020113199A1 (en) | Recombinant hiv env polypeptides and their use | |
| Baessler et al. | Adiponectin multimeric forms but not total adiponectin levels are associated with myocardial infarction in non-diabetic men | |
| RU2018109920A (ru) | Специфически очищенные антитела против пресепсина | |
| KR20180115307A (ko) | 가교화 피브린 분해 산물의 측정 시약 및 측정 방법 | |
| WO2019129679A1 (en) | Method for improving vegf-receptor blocking selectivity of an anti-vegf antibody | |
| US20190079080A1 (en) | Antibody specific to profilaggrin c-terminal domain, and use thereof | |
| Hoshi et al. | Surface X-ray scattering of high index plane of platinum containing kink atoms in solid–liquid interface: Pt (3 1 0)= 3 (1 0 0)–(1 1 0) | |
| Noah et al. | Assessing GastroPanel serum markers as a non-invasive method for the diagnosis of atrophic gastritis and Helicobacter pylori infection | |
| Bhandari et al. | The midregional portion of proadrenomedullin is an independent predictor of left ventricular mass index in hypertension | |
| US20110033894A1 (en) | Engineering surface epitopes to improve protein crystallization | |
| Wallis | Mammalian genome projects reveal new growth hormone (GH) sequences: Characterization of the GH-encoding genes of armadillo (Dasypus novemcinctus), hedgehog (Erinaceus europaeus), bat (Myotis lucifugus), hyrax (Procavia capensis), shrew (Sorex araneus), ground squirrel (Spermophilus tridecemlineatus), elephant (Loxodonta africana), cat (Felis catus) and opossum (Monodelphis domestica) | |
| EP4255928A1 (en) | Il-7 binding proteins and their use in medical therapy | |
| Imai et al. | Development of a novel immunoassay specific for mouse intact proinsulin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA93 | Acknowledgement of application withdrawn (no request for examination) |
Effective date: 20131105 |